<DOC>
	<DOC>NCT02549001</DOC>
	<brief_summary>The purpose of this study is to determine whether P-3058 nail solution is a safe and effective treatment for onychomycosis.</brief_summary>
	<brief_title>Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis</brief_title>
	<detailed_description />
	<mesh_term>Onychomycosis</mesh_term>
	<mesh_term>Amorolfine</mesh_term>
	<criteria>Written informed consent Patients aged 12 years and older of any race. Males or females. Patients with onychomycosis involving ≥ 20% to ≤ 50% of target big toenail. Patients with a positive KOH examination and culture positive for dermatophyte Presence of "yellow spikes" on the target nail. Presence of dermatophytoma on the target nail. Presence of nail thickness exceeding 2 mm. Patients with proximal subungual involvement Patients with severe plantar or moccasin tinea pedis Patients with nail abnormalities due to other conditions Patients with life expectancy less than 2 years. Chemotherapy, immunosuppressive therapy in the 12 weeks prior to Screening visit (V1). Systemic corticosteroids, antimetabolites and immunestimulants therapy in the 4 weeks prior to Screening visit (V1). HIV infection or any other immunodeficiency. Alcohol or substance abuse. Patients with history of allergic reactions to terbinafine or its excipients. Woman who is pregnant, nursing an infant, or planning a pregnancy during the study period.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Onychomycosis</keyword>
	<keyword>Nail fungus</keyword>
</DOC>